-
Research and Markets
Laura Wood, Senior Manager
-
Research and Markets
Laura Wood, Senior Manager.
-
DUBLIN -- Dublin - Research and Markets (http://www.researchandmarkets.com/research/nkt6w6/understanding_medi) has announced the addition of John Wile...
-
The Food and Drug Administration (FDA) is announcing a public workshop entitled ``Design and Methodology for Postmarket Surveillance Studies under Section 522 of the Federal Food, Drug and Cosmetic Act''. The purpose of the public workshop is to provide a forum for discussion among FDA, industry, governmental agencies, academia, clinicians and various stakeholders with experience in epidemiology, statistics, and biomedical research to advance the design and methodologies for medical device surveillance studies in the ``postmarket'' setting, i.e., after FDA premarket approval or clearance of the device and marketing of the device has begun.
-
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/c99156/medical_home_case) has announced the addition of the "Medical Home C...
-
UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT SUMMARY ORDER THIS SUMMARY ORDER WILL NOT BE PUBLISHED IN THE FEDERAL REPORTER AND MAY NOT BE CI...
-
To: TECHNOLOGY EDITORS
Contact: Axel Bang, +1-914-234-5433, abang@axelbang.com, for Montefiore Medical Center; or Anne McDarby of Montefiore Medical Center, +1-718-920-4011, amcdarby@montefiore.org
-
LOS ANGELES - Publication bias: It has long been a problem in medical research. Studies that show a drug or treatment is effective are more likely to be published than studies with negative findings. As a result, the medical literature that guides how diseases and disorders are treated often provides doctors an incomplete picture of the evidence.
A case in point is the use of antidepressants to treat the repetitive behaviors - including hoarding, tapping, head banging and strict adherence to routine - that are a hallmark of autism.
-
To: NATIONAL EDITORS
Contact: Cathy Lewis, +1-214-706-1324, Julie Del Barto, +1-214- 706-1330, (broadcast only), or Dr. Timothy Gardner, +1-302-733- 1241, tgardner@christianacare.org, all of the American Heart Association
-
Researchers at the Oklahoma Medical Research Foundation are seeking rheumatoid arthritis and lupus patients to take part in studies of new treatments for the diseases.
OMRF's Clinical Pharmacology Research Program conducts pharmaceutical studies on rheumatoid arthritis and lupus.